HEALTHNY POST
Women on Ozempic-like drugs are 30% less likely to develop breast cancer: study
A study from the University of Pennsylvania School of Medicine found that women using Ozempic-like drugs are 30% less likely to develop breast cancer, suggesting these weight loss medications may also serve as cancer prevention tools.
Mentioned
Related Signal
Adjacent reporting
- GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study
- GLP-1 drugs may reduce the risk of cancer progressing, study suggests
- Weight-loss jabs could cut breast cancer risk by nearly a third, major study suggests
- Weight-loss jabs could cut breast cancer risk by nearly a third, major study suggests
- Ozempic-style drugs linked to major slowdown in cancer spread, new study finds
- Weight loss jabs may help stop cancer from spreading, study reveals